Influence of Chemotherapy on EGFR Mutation Status Among Patients With Non–Small-Cell Lung Cancer

PURPOSE: EGFR mutation is a predictor of epidermal growth factor receptor–tyrosine kinase inhibitor treatment response in patients with non–small-cell lung cancer (NSCLC). However, it remains unclear whether chemotherapy affects EGFR mutation status in NSCLC. We investigated the influence of chemoth...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Oncol
Hlavní autoři: Bai, Hua, Wang, Zhijie, Chen, Keneng, Zhao, Jun, Lee, J. Jack, Wang, Shuhang, Zhou, Qinghua, Zhuo, Minglei, Mao, Li, An, Tongtong, Duan, Jianchun, Yang, Lu, Wu, Meina, Liang, Zhen, Wang, Yuyan, Kang, Xiaozheng, Wang, Jie
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2012
Témata:
ORIGINAL REPORTS
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5321076/
https://ncbi.nlm.nih.gov/pubmed/22826274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.39.3744
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky